A citation-based method for searching scientific literature

Hsien-Neng Huang, Chun-Wei Kuo, Ming-Chieh Lin, Tsui-Lien Mao, Kuan-Ting Kuo. Appl Immunohistochem Mol Morphol 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
100

The PTEN⁻PI3K Axis in Cancer.
Antonella Papa, Pier Paolo Pandolfi. Biomolecules 2019
94
50

Non-BRCA familial breast cancer: review of reported pathology and molecular findings.
Michael G Keeney, Fergus J Couch, Daniel W Visscher, Noralane M Lindor. Pathology 2017
16
50

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.
Luisa Carbognin, Federica Miglietta, Ida Paris, Maria Vittoria Dieci. Cancers (Basel) 2019
36
50

Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia, Manuela Zavatti, Marco Vinceti, Alberto M Martelli, Sandra Marmiroli. Biochim Biophys Acta Mol Cell Res 2020
30
50

PTEN Overexpression Cooperates With Lithium to Reduce the Malignancy and to Increase Cell Death by Apoptosis via PI3K/Akt Suppression in Colorectal Cancer Cells.
Wallace Martins de Araujo, Bruno Kaufmann Robbs, Lilian G Bastos, Waldemir F de Souza, Flávia C B Vidal, João P B Viola, Jose A Morgado-Diaz. J Cell Biochem 2016
31
50

PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Xiao-Ping Zhou, Anu Loukola, Reijo Salovaara, Minna Nystrom-Lahti, Päivi Peltomäki, Albert de la Chapelle, Lauri A Aaltonen, Charis Eng. Am J Pathol 2002
150
50

The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities.
Hyeyoun Chang, Zhenying Cai, Thomas M Roberts. Biomolecules 2019
9
50


Cell Cycle Control by PTEN.
Andrew Brandmaier, Sheng-Qi Hou, Wen H Shen. J Mol Biol 2017
52
50


Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.
Angela S Cheng, Samuel C Y Leung, Dongxia Gao, Samantha Burugu, Meenakshi Anurag, Matthew J Ellis, Torsten O Nielsen. Breast Cancer Res Treat 2020
21
50

The PI3K Pathway in Human Disease.
David A Fruman, Honyin Chiu, Benjamin D Hopkins, Shubha Bagrodia, Lewis C Cantley, Robert T Abraham. Cell 2017
984
50

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.
Adam Naguib, James C Cooke, Lisa Happerfield, Lucy Kerr, Laura J Gay, Robert N Luben, Richard Y Ball, Panagiota N Mitrou, Alison McTaggart, Mark J Arends. BMC Cancer 2011
56
50

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
Steven Lemery, Patricia Keegan, Richard Pazdur. N Engl J Med 2017
331
50

PTEN mutations as a cause of constitutive insulin sensitivity and obesity.
Aparna Pal, Thomas M Barber, Martijn Van de Bunt, Simon A Rudge, Qifeng Zhang, Katherine L Lachlan, Nicola S Cooper, Helen Linden, Jonathan C Levy, Michael J O Wakelam,[...]. N Engl J Med 2012
156
50

Emerging role of PTEN loss in evasion of the immune response to tumours.
Thiago Vidotto, Camila Morais Melo, Erick Castelli, Madhuri Koti, Rodolfo Borges Dos Reis, Jeremy A Squire. Br J Cancer 2020
35
50

Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation.
Zan Chen, Daniel R Dempsey, Stefani N Thomas, Dawn Hayward, David M Bolduc, Philip A Cole. J Biol Chem 2016
27
50

Cancer phenomics: RET and PTEN as illustrative models.
Kevin M Zbuk, Charis Eng. Nat Rev Cancer 2007
172
50

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.
M G Butler, M J Dasouki, X-P Zhou, Z Talebizadeh, M Brown, T N Takahashi, J H Miles, C H Wang, R Stratton, R Pilarski,[...]. J Med Genet 2005
519
50

Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
Jianhui Ma, Jorge A Benitez, Jie Li, Shunichiro Miki, Claudio Ponte de Albuquerque, Thais Galatro, Laura Orellana, Ciro Zanca, Rachel Reed, Antonia Boyer,[...]. Cancer Cell 2019
12
50


Functions and Regulation of the PTEN Gene in Colorectal Cancer.
Francesca Molinari, Milo Frattini. Front Oncol 2014
73
50

The functions and regulation of the PTEN tumour suppressor: new modes and prospects.
Yu-Ru Lee, Ming Chen, Pier Paolo Pandolfi. Nat Rev Mol Cell Biol 2018
335
50

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
470
50

Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer.
Milo Frattini, Stefano Signoroni, Silvana Pilotti, Lucio Bertario, Silvia Benvenuti, Carlo Zanon, Alberto Bardelli, Marco A Pierotti. Cancer Res 2005
42
50

The Intra-S Checkpoint Responses to DNA Damage.
Divya Ramalingam Iyer, Nicholas Rhind. Genes (Basel) 2017
55
50

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors.
Pedram Razavi, Maura N Dickler, Payal D Shah, Weiyi Toy, David N Brown, Helen H Won, Bob T Li, Ronglai Shen, Neil Vasan, Shanu Modi,[...]. Nat Cancer 2020
52
50

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around.
Anastasios Gkountakos, Giulia Sartori, Italia Falcone, Geny Piro, Ludovica Ciuffreda, Carmine Carbone, Giampaolo Tortora, Aldo Scarpa, Emilio Bria, Michele Milella,[...]. Cancers (Basel) 2019
41
50


Inherited PTEN mutations and the prediction of phenotype.
Nicholas R Leslie, Michel Longy. Semin Cell Dev Biol 2016
53
50

Discovery and saturation analysis of cancer genes across 21 tumour types.
Michael S Lawrence, Petar Stojanov, Craig H Mermel, James T Robinson, Levi A Garraway, Todd R Golub, Matthew Meyerson, Stacey B Gabriel, Eric S Lander, Gad Getz. Nature 2014
50

PI(3,4)P2 Signaling in Cancer and Metabolism.
Luca Gozzelino, Maria Chiara De Santis, Federico Gulluni, Emilio Hirsch, Miriam Martini. Front Oncol 2020
26
50

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.
Lauren M Thorpe, Haluk Yuzugullu, Jean J Zhao. Nat Rev Cancer 2015
780
50

PTEN: Tumor Suppressor and Metabolic Regulator.
Chien-Yu Chen, Jingyu Chen, Lina He, Bangyan L Stiles. Front Endocrinol (Lausanne) 2018
165
50

Regulation and modulation of PTEN activity.
Elahe Naderali, Amir Afshin Khaki, Jafar Soleymani Rad, Alireza Ali-Hemmati, Mohammad Rahmati, Hojjatollah Nozad Charoudeh. Mol Biol Rep 2018
36
50

High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.
Seung Eun Lee, Hye Seung Lee, Kyoung-Yeon Kim, Jung-Hoon Park, Hanseong Roh, Ha Young Park, Wan-Seop Kim. Sci Rep 2019
10
50

PTEN in DNA damage repair.
Mei Ming, Yu-Ying He. Cancer Lett 2012
96
50

Epigenetic silencing of the PTEN gene in melanoma.
Alireza Mirmohammadsadegh, Alessandra Marini, Sandeep Nambiar, Mohamed Hassan, Andrea Tannapfel, Thomas Ruzicka, Ulrich R Hengge. Cancer Res 2006
190
50

PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.
Haoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, Stephanie M Zimmerman, Gerald C Chu, Haiyan Yan, Eliot Fletcher-Sananikone, Hailei Zhang, Yingchun Liu, Wei Wang,[...]. Cancer Discov 2011
158
50

Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis.
Miho Iijima, Yi Elaine Huang, Hongbo R Luo, Francisca Vazquez, Peter N Devreotes. J Biol Chem 2004
156
50

PTEN as a Guardian of the Genome: Pathways and Targets.
Xinyi Fan, Jeffrey Kraynak, Jonathan P S Knisely, Silvia C Formenti, Wen H Shen. Cold Spring Harb Perspect Med 2020
8
50

Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
Yoshiya Horimoto, May Thinzar Hlaing, Harumi Saeki, Shigehisa Kitano, Katsuya Nakai, Ritsuko Sasaki, Aiko Kurisaki-Arakawa, Atsushi Arakawa, Naomi Otsuji, Shuji Matsuoka,[...]. Cancer Sci 2020
17
50

Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
Robert Pilarski, Randall Burt, Wendy Kohlman, Lana Pho, Kristen M Shannon, Elizabeth Swisher. J Natl Cancer Inst 2013
259
50

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options.
Giulia Grizzi, Michele Ghidini, Andrea Botticelli, Gianluca Tomasello, Antonio Ghidini, Francesco Grossi, Nicola Fusco, Mary Cabiddu, Tommaso Savio, Fausto Petrelli. Cancer Manag Res 2020
19
50

Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.
Ty W Abel, Suzanne J Baker, Melissa M Fraser, Tarik Tihan, James S Nelson, Anthony T Yachnis, John-Paul Bouffard, Hernando Mena, Peter C Burger, Charles G Eberhart. J Neuropathol Exp Neurol 2005
56
50

PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.
Prerna Malaney, Emily Palumbo, Jonathan Semidey-Hurtado, Jamaal Hardee, Katherine Stanford, Jaymin J Kathiriya, Deepal Patel, Zhi Tian, Diane Allen-Gipson, Vrushank Davé. Cell Cycle 2018
17
50

Structural Mechanisms of PTEN Regulation.
Glenn R Masson, Roger L Williams. Cold Spring Harb Perspect Med 2020
19
50

Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.
Dejan Juric, Pau Castel, Malachi Griffith, Obi L Griffith, Helen H Won, Haley Ellis, Saya H Ebbesen, Benjamin J Ainscough, Avinash Ramu, Gopa Iyer,[...]. Nature 2015
349
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.